Home > Clinical Trials

Saved trials

Terminated
NCT04606563
Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?
341 Enrollment(s)
13 Study location(s)
Interventional (Phase III)
Covid19
SARS-CoV Infection
Active, not recruiting
NCT04594915
Evaluation of Treatment Safety in Patients With Atrial Fibrillation on Edoxaban Therapy in Real-Life in Turkey
1,053 Enrollment(s)
45 Study location(s)
Observational
Atrial Fibrillation
Not yet recruiting
NCT05723510
PK and PD Interaction Between Tegoprazan and NOACs After Multiple Oral Dosing in Healthy Volunteers
76 Enrollment(s)
0 Study location(s)
Interventional (Phase I)
Healthy
Completed
NCT01944800
Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome
4,018 Enrollment(s)
19 Study location(s)
Interventional (Phase IV)
Acute Coronary Syndrome (ACS)
Completed
NCT03882177
StAT-TB (Statin Adjunctive Therapy for TB): A Phase 2b Dose-finding Study of Pravastatin in Adults With Tuberculosis
35 Enrollment(s)
1 Study location(s)
Interventional (Phase II)
Tuberculosis
Pulmonary Tuberculosis
Completed
NCT04796831
A Study to Determine the Absolute Oral Bioavailability of Quizartinib Using a Radiolabeled Microtracer in Healthy Subjects
8 Enrollment(s)
1 Study location(s)
Interventional (Phase I)
Healthy Subjects
Recruiting
NCT04297150
Predictive Factors for Response to New Oral Anticoagulants in the Treatment of Non-valvular Atrial Fibrillation..
700 Enrollment(s)
6 Study location(s)
Observational
Atrial Fibrillation
Completed
NCT03757481
Long-term Outcome After Heparin and Edoxaban Versus Heparin Plus Vit K Antagonists for Acute DVT and PE
156 Enrollment(s)
11 Study location(s)
Interventional (Not Applicable)
Post Thrombotic Syndrome
Deep Vein Thrombosis
Chronic Thromboembolic Pulmonary Hypertension